Our mission is to unite and align key diabetes stakeholders and the larger diabetes community around key
diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.

Care

DAA’s 2018 Advocacy Priorities. Since the many serious health complications of diabetes can largely be prevented with proper treatment and care, the Diabetes Advocacy Alliance (DAA) strongly supports policies improving the care of people with diabetes. (Click here for a complete list of the DAA’s 2018 Advocacy Priorities.)

It is critical that people with diabetes have access to a team of health care professionals, medications, devices, and self-management education to help them manage their diabetes successfully. To help drive optimal outcomes for people with diabetes, it also is vital that there be sufficient insurance coverage as well as sound quality measures for high-quality diabetes care.




Tools & Technologies
Diabetes is a complex disease that requires ongoing self-management by patients, including making numerous decisions throughout the day, as part of their management and treatment regimen. People with diabetes need access to a range of tools and technologies including new innovations that help them and their caregivers monitor and manage their disease.

Diabetes Self-Management Training (DSMT)
Despite that fact that diabetes self-management training is a covered benefit under the Medicare program, only 5% of Medicare beneficiaries with newly diagnosed diabetes participate in this evidence-based service. The Centers for Medicare and Medicaid Services (CMS) recognizes the significant underutilization of DSMT and is committed to reducing barriers contributing to the underutilization of the benefit. In addition to regulatory reforms, legislation is also crucial to expand access to diabetes self-management training (DSMT) so older adults with diabetes can prevent costly complications by designating qualified and credentialed diabetes educators as Medicare providers of DSMT.

Access to Providers
People with diabetes rely on a team of health care professionals to assist them in managing their disease which is why access to providers is so important. Primary care physicians, endocrinologists, optometrists/ophthalmologists, podiatrists, internists, cardiologists, pharmacists, dietitians, diabetes educators and many more help people with diabetes manage their disease, prevent complications, or manage complications as they arise.

Telehealth
Telehealth is a useful tool for providing effective management for people with diabetes and those at risk. Expanded access, coverage and use of telehealth has the potential to improve health outcomes for people with diabetes and those at risk while saving money.

National Clinical Care Commission
Implementation of the National Clinical Care Commission, comprised of private sector experts, including health care professionals and patient advocates, and representatives from the federal agencies, will improve the implementation and coordination of federal clinical care initiatives for patients with complex metabolic or autoimmune disease, diabetes, or complications caused by such diseases.

Quality Measures
Measuring the quality of care for people with diabetes can provide useful information on how the health care system performs and ultimately help improve care for people with chronic diseases like diabetes. While dozens of diabetes quality measures have been developed, a major gap exists in that current measures do not address prediabetes/diabetes screening and referral to diabetes prevention programs. Advancing quality measures tied to screening and prevention is essential to ensuring that people with diabetes and those at-risk receive optimal care.

High-Quality and Affordable Insurance
People with diabetes and those at-risk for developing diabetes have benefited from reforms in the Affordable Care Act. As policymakers look to reform the health insurance market and the health care system, the needs of people with chronic diseases like diabetes and people at-risk for developing the disease must be a priority to ensure that high-quality and affordable insurance is available and accessible.